Tuesday, January 28, 2025
10-11am ET • 9-10am CT • 7-8am PT
 |
Register by January 24 |
Program Description
As a new administration enters the White House in the US, life sciences companies and investors are preparing for potential changes in the regulatory, compliance, and enforcement environment. Join our global Life Sciences Regulatory & Compliance team to hear about the most noteworthy developments emanating from DC, as well as key regulatory issues to watch in Europe, the UK, and Asia that are likely to impact life sciences companies in 2025.
Topics of discussion will include:
- HHS/FDA leadership changes and expected policy priorities
- Effects on digital health/AI policy
- Implications for medical product development and use of real-world data
- Potential shifts in enforcement and inspection priorities
- Regulatory developments in Europe, the UK, and Asia with cross-border implications
CLE information Contact info RGEvents@ropesgray.com
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find out more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.